|
|
| March 9, 2013: Dr. Masahiro Natsuaki and Dr. Matthew Cavender discuss: One-Year Outcome of a Trial Comparing Second Generation Drug-Elu |
Dr. Masahiro Natsuaki and Dr. Matthew Cavender discuss: One-Year Outcome of a Trial
Comparing Second Generation Drug-Eluting Stents Using Either Biodegradable Polymer or
Durable Polymer: the NOBORI TM Biolimus-Eluting versus XIENCE TM/PROMUS TM
Everolimus-Eluting Stent Trial (NEXT)
This authors of this submission report no disclosures.
[ Download video ] |
|
No comments have been submitted
|